Tom Beard

Morgan Stanley Australia Ltd. is an Australian broker/dealer subsidiary of Morgan Stanley International, Inc., itself owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in Sydney, the firm offers sales, trading and market-making investment management services to global institutions, hedge funds and industry innovators.

Uniseed Management Pty Ltd. (Uniseed) is an independent Australian venture capital firm which was founded in 2000. The firm headquartered in Australia.

Southmore Capital Pty Ltd (Southmore) is a venture capital firm is founded in 2006 by Dr. Jurgen Michaelis. The firm is headquartered in Adelaide.

Lanyon Asset Management Pty Ltd. (LAM) is an independent hedge fund manager headquartered in Sydney which was founded in 2009. LAM manages equity funds and also offers individual client mandates. Their clients include institutional, retail investors, superannuation funds, university endowments, philanthropic organizations, family offices, SMSF’s and private investors.

Sapien Ventures Investment Management Pty Ltd (Sapien Ventures) is a venture capital subsidiary of Sapien Group Pty Ltd founded in 2015 by Victor Jiang. The firm is headquartered in Sydney, Australia.

Myriota Pty Ltd. manufactures and distributes low power micro transmitters which provides access to high value small data in remote locations. It solutions are used in resource sector asset, pumping assets, horticulture, livestock, irrigation and rain measurement areas. The firm serves data-driven agriculture, oil and gas, environmental monitoring and defense sectors. The company was founded by David Haley and Alexander James Grant in November 2015 and is headquartered in Adelaide, Australia.

Ferronova Pty Ltd. operates as a bionanoengineering company. Its research activities focuses on interface of materials science, nanoscience, bioengineering, and medicine. It develops an enhanced cancer detecting magnetic probe system. The company was founded on May 27, 2016 and is headquartered in Adelaide, Australia.

Biomebank is an Australian clinical stage biotechnology company that aims to prevent diseases by restoring gut microbial ecology through microbiome-based therapies. The company is based in Thebarton, Australia. Biomebank's product is the world's first approved microbiome-based therapy for the treatment of recurrent and refractory clostridioides difficile infection. The company was founded by Rob Bryant and Sam Costello, with Sam Costello serving as the CEO since incorporation.

Bio Innovation SA promotes biotechnology development projects. It offers start-ups and early stage customized programs including grants, business and marketing assistance, lab and office space and access to global networks. The company was founded in 2001 and is headquartered in Thebarton, Australia.